Rocket Lab (RKLB) has slipped to $49.76, a 24.8% drop from its recent $66.15 peak, and the balance of evidence still points to a bearish short‑term outlook. The daily trend follows a weekly downtrend, the stock lags the S&P 500 by 13.5% over the past 50 days, and the breakout math signals a downside target near the 52‑week low of $39.48. The story has not changed since the November 3 assessment; the same technical and relative‑strength weaknesses remain in place.
Why it matters
The most recent catalyst was the announcement that Rocket Lab’s Neutron rocket launch has been delayed to 2027, a setback that kept the shares falling despite a 73% year‑over‑year revenue jump to $268 million and a growing backlog of $3.6 billion. The earnings beat was priced in quickly, as evidenced by the 5‑day stock decline of 19.1% versus a 5.4% drop in the S&P 500, showing that the move was driven more by the stock itself than by the broader market.
Prior to the earnings, the market had already priced in a steep correction. Institutional buying by ARK Invest and a $189.3 million position by Paul Tudor Jones were noted, but both were dwarfed by the broader sell‑off and the fact that the stock now trades well below its 50‑day moving average of $61.43 and its 200‑day average of $77.74. Volume is down 95% versus the 20‑day average, indicating a lack of buying interest even as the sector sees a $9.8 billion VLEO satellite investment forecast through 2031.
Analyst consensus remains a “buy” with a mean target of $93.15, but that target is 46.6% above the current price, reflecting a valuation gap that has not narrowed. The spread between the low target ($58) and the current price ($49.76) is still wide, underscoring the disconnect between analyst optimism and market reality.
Debate in the media is split. Jim Cramer called the stock “too cheap” and a speculative buy after the five‑session decline, while other commentary highlighted the need for the Neutron rocket to deliver before any upside can be justified. The bullish arguments focus on the revenue surge and the $645 million space‑systems revenue line, but the downside risk remains anchored to execution risk on Neutron and the continued weakness relative to the S&P 500.
What the evidence says
Long‑term, the thesis that Rocket Lab is a growth story in the aerospace and defense sector is still intact, but the price action has moved the stock into a defensive phase. The price sits below both the 40‑week average and the 52‑week high, and the RSI of 39.6 signals that the stock is approaching oversold territory without a clear reversal signal.
For the next two to six weeks, the balance of evidence leans negative with medium conviction. The daily trend runs with the weekly downtrend, and the stock is lagging the S&P 500 by 13.5% over 50 days. The breakout math calls for a downside breakout below $45, a stop at $51.3, and a target at the 52‑week low of $39.48, giving a reward‑to‑risk of 0.9. The math does not meet a 3‑to‑1 risk‑reward, which is why conviction remains medium rather than high.
The strongest case against this reading would be a weekly close above the swing‑zone level of $63.98, which would suggest the weekly trend is ending. Even a close above the 50‑day SMA at $61.43 would weaken the downside bias, but neither has occurred, and the price remains well below those thresholds.
Levels that matter
The structure holds the price below the round $50 level, a zone where sellers have historically stepped in on rallies. The weekly trend would only end if the price can close above the swing‑zone resistance at $63.98, a level that also marks the upper edge of the recent consolidation zone.
The breakout math is straightforward: a daily close below the round $45 level would trigger the downside scenario, with a stop set at $51.3 (the $50 round level plus a quarter of the 14‑day ATR of $5.22). The target is the 52‑week low of $39.48, yielding a reward‑to‑risk of 0.9. Because the math does not achieve a 3‑to‑1 ratio, a price move to roughly $30 would be needed to make the risk‑reward attractive.
What would change the picture
A weekly close above the swing‑zone level of $63.98 would alter the narrative, indicating that the weekly downtrend has been broken. The non‑price catalyst that could also shift the outlook is a confirmed launch date for the Neutron rocket in 2027, which would address the execution risk that underpins the current downside bias.
What to watch
- Next earnings release on November 9; the key number will be adjusted EBITDA guidance, which the company says should turn positive within six months of the Neutron first flight.
- Sector events: any acceleration in VLEO satellite investment or a major contract win for Rocket Lab could provide a short‑term lift.
- Valuation: the consensus “buy” rating with a mean target of $93.15 remains 46.6% above the current price, highlighting a sizable gap that the market has yet to bridge.